Vaccinations have been completed and Valneva expects VALOR trial outcomes to be announced in the first half of 2026, followed by regulatory submissions as planned. Pfizer aims to submit a Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback